tiprankstipranks
Advertisement
Advertisement

Yidu Tech Wins RMB9 Million Smart Clinical Upgrade Project at Sun Yat-sen University Cancer Center

Story Highlights
  • Yidu Tech’s affiliate Yidu Cloud secured a RMB9.08 million project to upgrade smart clinical and settlement services at Sun Yat-sen University Cancer Center.
  • The contract strengthens Yidu Tech’s role in China’s smart healthcare transformation, embedding its AI-driven decision tools in real-world clinical and financial workflows.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Yidu Tech Wins RMB9 Million Smart Clinical Upgrade Project at Sun Yat-sen University Cancer Center

Meet Samuel – Your Personal Investing Prophet

The latest update is out from Yidu Tech, Inc. ( (HK:2158) ).

Yidu Tech Inc. has announced that its affiliate Yidu Cloud (Beijing) Technology Co., Ltd. has secured a contract worth approximately RMB9.08 million to undertake the Smart Clinical and Settlement Service Upgrade Construction Project for Sun Yat-sen University Cancer Center, Guangdong Branch of Bank of China Limited. The project underscores Yidu Tech’s growing role in deploying AI-driven clinical and settlement solutions in major Chinese healthcare institutions, reinforcing its position as a key enabler of digital and intelligent transformation across the medical ecosystem.

The win supports the company’s strategy of embedding its AI that “truly understands diseases” into real-world clinical workflows, potentially improving efficiency and precision in both medical decision-making and financial settlement processes at the cancer center. For stakeholders, this contract not only adds to Yidu Tech’s project backlog but also showcases the commercial adoption of its proprietary system-level intelligence, which could strengthen its competitive positioning in China’s rapidly evolving smart healthcare market.

More about Yidu Tech, Inc.

Yidu Tech Inc. is a healthcare technology company focused on driving the intelligent upgrading of China’s healthcare system through AI and data-driven solutions. Its core offerings span intelligent decision-making tools that support healthcare services, pharmaceuticals, insurance and patients, aiming to make precision healthcare more accessible and affordable. By simulating physicians’ clinical decision-making and training models on real disease progression, the company provides system-level intelligence to improve diagnostics, treatment and public health management.

Average Trading Volume: 6,956,912

Technical Sentiment Signal: Buy

Current Market Cap: HK$6.6B

See more insights into 2158 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1